SIRINGO, MARCO
 Distribuzione geografica
Continente #
EU - Europa 361
NA - Nord America 130
AS - Asia 104
OC - Oceania 4
AF - Africa 3
SA - Sud America 2
Totale 604
Nazione #
IT - Italia 275
US - Stati Uniti d'America 122
SG - Singapore 40
ES - Italia 22
IN - India 22
KR - Corea 16
FR - Francia 10
GB - Regno Unito 9
SE - Svezia 9
FI - Finlandia 8
DE - Germania 7
BG - Bulgaria 6
CA - Canada 5
CH - Svizzera 5
CN - Cina 5
AU - Australia 4
IE - Irlanda 3
IL - Israele 3
MX - Messico 3
BE - Belgio 2
HK - Hong Kong 2
JO - Giordania 2
JP - Giappone 2
MO - Macao, regione amministrativa speciale della Cina 2
MY - Malesia 2
NL - Olanda 2
PH - Filippine 2
PK - Pakistan 2
ZA - Sudafrica 2
AR - Argentina 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
RU - Federazione Russa 1
TG - Togo 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 604
Città #
Rome 105
Singapore 20
Milan 17
Perugia 13
Fairfield 12
Florence 12
Barcelona 11
Ashburn 10
Madrid 9
Naples 9
Salt Lake City 8
Helsinki 6
New York 6
Sofia 6
Pomezia 5
Boston 4
Chandler 4
Genoa 4
Goyang-si 4
Imperia 4
Princeton 4
Santa Clara 4
Albano Laziale 3
Bengaluru 3
Dongjak-gu 3
Dublin 3
Faenza 3
Geneva 3
Paris 3
Tel Aviv 3
Wilmington 3
Amman 2
Amsterdam 2
Artena 2
Bergamo 2
Bhubaneswar 2
Boardman 2
Brighton 2
Brisbane 2
Brugherio 2
Catania 2
Changsha 2
Chicago 2
Columbus 2
Corato 2
Hyderabad 2
Imola 2
Incheon 2
Jena 2
Johannesburg 2
Kolkata 2
Lahore 2
Lappeenranta 2
Locate di Triulzi 2
Los Angeles 2
Macao 2
Manresa 2
Mapo-gu 2
Messina 2
Mexico City 2
Millbury 2
Misterbianco 2
Montreal 2
Monza 2
Morlupo 2
Newton 2
Philadelphia 2
Portland 2
Ravenna 2
Roanoke 2
Ruislip 2
Santa Maria a Vico 2
Schlieren 2
Seoul 2
Stockholm 2
Thiene 2
Tokyo 2
Toronto 2
Turin 2
Vallefoglia 2
Venice 2
Washington 2
Willingboro 2
Wilmslow 2
Andover 1
Ankara 1
Arezzo 1
Austin 1
Beauharnois 1
Bellingham 1
Bentivoglio 1
Beringen 1
Beverly Hills 1
Bishkek 1
Brussels 1
Budapest 1
Cagliari 1
Cambridge 1
Charlottesville 1
Cinisello Balsamo 1
Totale 426
Nome #
Selective Internal Radiation Therapy (SIRT): a new emerging role for Breast Cancer Liver Metastases 69
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study 68
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease 57
Circulating CD137+T cells as an immune biomarker for response to anti-PD1 immunotherapy in NSCLC patients 54
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors 51
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line 48
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort 37
Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer 33
Treg/CD137+ T cell balance as a novel biomarker of survival in advanced non-addicted NSCLC patients treated with immunotherapy as first-line 31
Circulating CD137+ T cell subsets and MDCSs as immune biomarkers for response to anti-PD1 immunotherapy in NSCLC patients 29
Evaluation of efficacy of ALK inhibitors according to body mass index in ALK rearranged NSCLC patients—A retrospective observational study 26
ADJUVANT TREATMENT IN ELDERLY CANCER PATIENTS: A MULTICENTER REAL-LIFE EXPERIENCE 25
null 17
EP08.02-046 Activity of OsimeRTInib in NSCLC with Uncommon EGFR Mutations: Retrospective Observational Multicenter Study (ARTICUNO) 14
Clinical utility of combined plasma and tissue NGS in patients with advanced, treatment-naïve, Non-small Cell Lung Cancer 14
Co-Occurrence of ALK rearrangement and KRAS G12C mutation in NSCLC: Report of two cases 13
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy 13
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy 12
Adjuvant treatment in elderly cancer patients: a multicenter real-life experience 11
Clinical Utility of Combined Plasma and Tissue NGS in Patients With Newly Diagnosed Advanced Non-Small Cell Lung Cancer 11
Comparison between liquid biopsy and tissue NGS in two cohorts of advanced NSCLC 10
Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease 5
Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer 4
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed 2
Totale 654
Categoria #
all - tutte 2.668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.668


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 0 2
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/202248 2 0 1 1 2 2 4 1 10 1 19 5
2022/202359 8 4 2 5 4 6 3 10 0 2 4 11
2023/2024416 13 16 9 23 58 71 31 19 2 50 58 66
2024/2025121 55 46 20 0 0 0 0 0 0 0 0 0
Totale 654